Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Samantha K. Kurosky"'
Autor:
Egbe Ubamadu, Estefania Betancur, Bradford D. Gessner, Sonia Menon, Hilde Vroling, Daniel Curcio, Mark Rozenbaum, Samantha K. Kurosky, Zuleika Aponte, Elizabeth Begier
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 7, Pp 1399-1417 (2024)
Abstract Introduction Respiratory syncytial virus (RSV) can cause severe respiratory infections in adults; however, information on associated sequelae is limited. This systematic literature review aimed to identify sequelae in adults within 1 year fo
Externí odkaz:
https://doaj.org/article/ab4d61f024b0481ba6292f5bbde248ea
Autor:
Mark H. Rozenbaum, Elizabeth Begier, Samantha K. Kurosky, Jo Whelan, Danai Bem, Koen B. Pouwels, Maarten Postma, Louis Bont
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 6, Pp 1487-1504 (2023)
Abstract Introduction Respiratory syncytial virus (RSV) is an important cause of severe respiratory illness in older adults and adults with respiratory or cardiovascular comorbidities. Published estimates of its incidence and prevalence in adult grou
Externí odkaz:
https://doaj.org/article/2dcda24587aa425884961159e00dcb08
Autor:
Martine C. Maculaitis, Xianchen Liu, Alexandra Berk, Angelina Massa, Marisa C. Weiss, Samantha K. Kurosky, Benjamin Li, Lynn McRoy
Publikováno v:
Current Oncology, Vol 30, Iss 4, Pp 3886-3900 (2023)
The impact of coronavirus disease 2019 (COVID-19) on the wellbeing of breast cancer (BC) patients is not well understood. This study described psychosocial problems among these patients in the United States (US) during the COVID-19 pandemic. Data wer
Externí odkaz:
https://doaj.org/article/c1d6e6d90b374a66842747ffc9cf1899
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 2, Pp 677-685 (2023)
Abstract Introduction Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI)-related hospitalizations in older adults. Without RSV-specific treatment for adults, testing is uncommon, leading to potential unde
Externí odkaz:
https://doaj.org/article/dbeec84a1fbf4f78956ac36ab52796b8
Autor:
Elizabeth M. La, Laurel Trantham, Samantha K. Kurosky, Dawn Odom, Emmanuel Aris, Cosmina Hogea
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 2, Pp 430-441 (2018)
Despite longstanding recommendations for routine vaccination against influenza; pneumococcal; tetanus, diphtheria, acellular pertussis (Tdap); and herpes zoster (HZ) among the United States general adult population, vaccine uptake remains low. Unders
Externí odkaz:
https://doaj.org/article/b562d1a8a8ad4e57ad99bc387f41bb04
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 11, Pp 2494-2502 (2017)
Vaccination at age-appropriate intervals increases protection against morbidity and mortality; however, compliance rates among children remain low partly due to a complicated vaccination schedule. Use of combination vaccines reduces the number of inj
Externí odkaz:
https://doaj.org/article/a41e2cacb9854fd5a280547f8e3502b6
Autor:
Adam M. Brufsky, Martine C. Maculaitis, Lewis Kopenhafer, Patrick Olsen, Ashley S. Cha, Lillian Shahied Arruda, Wendy Heck, Samantha K. Kurosky
Publikováno v:
Cancer Research. 83:P4-07
Background: Despite demonstrated clinical benefits of first line (1L) cyclin-dependent kinases 4/6 inhibitors (CDK4/6i) and their preferred status in the NCCN guidelines, many appropriate patients with hormone receptor positive (HR+)/human epidermal
Autor:
Neil Iyengar, Clay Williams, Michael Rogan, Laurie Campbell, Shirley Mertz, Jeremy Block, Maria Ebling, Connie Chen, Justin Doan, Samantha K. Kurosky, Timothy Pluard
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-147
Autor:
Ernest H. Law, Elena Galve-Calvo, Achim Wöckel, Rohan Parikh, Samantha K. Kurosky, Valerie Derrien Ansquer, Gaelle Frugier, Keith L. Davis, Elizabeth J. Esterberg, Olga Oikonomidou
Publikováno v:
Cancer Research. 82:OT2-19
Background: Palbociclib is currently the most commonly used cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) for patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in Eu
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 22(7)
To characterize workplace productivity measures in patients with metastatic breast cancer (mBC) using line of therapy (LOT) and first line (1 L) regimen. A retrospective cohort study was conducted using IBM’s MarketScan Commercial Claims and Encoun